Niagen Bioscience (NAGE) Change in Account Payables (2016 - 2025)
Niagen Bioscience (NAGE) has disclosed Change in Account Payables for 13 consecutive years, with -$1.9 million as the latest value for Q4 2025.
- Quarterly Change in Account Payables fell 186.03% to -$1.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.3 million through Dec 2025, up 312.75% year-over-year, with the annual reading at $2.3 million for FY2025, 312.75% up from the prior year.
- Change in Account Payables for Q4 2025 was -$1.9 million at Niagen Bioscience, down from -$938000.0 in the prior quarter.
- The five-year high for Change in Account Payables was $3.0 million in Q2 2025, with the low at -$2.3 million in Q1 2024.
- Average Change in Account Payables over 5 years is $99500.0, with a median of -$87500.0 recorded in 2021.
- The sharpest move saw Change in Account Payables tumbled 229.26% in 2022, then skyrocketed 1379.61% in 2025.
- Over 5 years, Change in Account Payables stood at -$381000.0 in 2021, then skyrocketed by 246.98% to $560000.0 in 2022, then soared by 84.64% to $1.0 million in 2023, then skyrocketed by 118.76% to $2.3 million in 2024, then tumbled by 186.03% to -$1.9 million in 2025.
- According to Business Quant data, Change in Account Payables over the past three periods came in at -$1.9 million, -$938000.0, and $3.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.